After selling Mazza, it became clear that our expertise was needed in a new area. Ben Lightburn, Filament Health’s CEO and Co-Founder, took note of the growing global mental health crisis. He believed that psychedelics could help, and that natural psychedelics would be the preferred choice.
Ben also recognized his unique position - he had the skills and experience to develop natural psychedelic drugs. By combining his background as entrepreneur with the botanical extraction expertise of the former Mazza Innovation team, Filament Health was created.